PRSS1 Mutation and Recurrent Pancreatitis: Does the Gene Change the Operation?
Carousel1 min read·Published Nov 2026

PRSS1 Mutation and Recurrent Pancreatitis: Does the Gene Change the Operation?

Title slide asking whether PRSS1 mutation affects surgical management in pediatric recurrent pancreatitis.
Diagram comparing normal pancreatic cell to PRSS1 mutation showing trypsinogen activation location differences.
Quote slide from Dr. Gurria on surgical approach for PRSS1 mutation patients in pancreatic disease management.
Slide explaining TPIAT as surgical option for hereditary pancreatitis with refractory pain in pediatric patients.
Slide explaining PRSS1 mutation significantly increases lifetime pancreatic cancer risk.
Slide explaining clinical implications of positive PRSS1 genetic test result for pancreatic disease management.
Final slide encouraging viewers to follow for more pediatric surgery education content on pancreas topics.
1 / 7

Carousel · Nov 2026 · 1 min read

In brief

In brief

Educational carousel covering pancreatic anatomy and pancreatitis, likely part of a clinical teaching series on pancreatic disorders and their management.

Written by the GCMD Library team from the carousel.

Slides

7 pages · click to turn to one
Pancreas — pancreatitis. A social-media carousel made possible by Cincinnati Children's.
The text on each slide
  1. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | A 2yoM with acute recurrent pancreatitis has a 10-gene pancreatitis gene panel that comes back positive for a PRSS1 mutation. | DOES THE GENE CHANGE THE OPERATION? | 1/7
  2. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | WHAT THE PANEL EXPLAINS | "IDIOPATHIC" WAS OFTEN GENETIC | In one center's registry of 1,000 children with pancreatitis, 80% carried an identifiable mutation. | Trypsinogen activates inside the gland instead of the duodenum. The pancreas digests itself, and these children can present at 1–3 years old. | NORMAL | PRSS1 MUTATION | Normal: activates in duodenum | PRSS1: activates in gland. | 2/7
  3. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | THE SURGEON'S VIEW | PRSS1 CHANGES THE OPERATION | I would be very hesitant to offer a segmental resection on a patient that has a [PRSS1] mutation. | Juan Pablo Gurria, MD, MSc | Surgical Director, Pancreas Care Center, Cincinnati Children's | 3/7
  4. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | WHAT TO DO INSTEAD | IF SURGERY IS NEEDED: TPIAT MIGHT BE THE BEST ANSWER TODAY | The indication for surgery is refractory pain, not cancer prophylaxis. | Every remaining cell carries the mutation. A partial resection leaves diseased gland behind, and the pancreatitis continues. | Total pancreatectomy with islet autotransplantation (TPIAT) causes surgical diabetes. The islet autotransplant reduces it, but many children still need some insulin. | 4/7
  5. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | THE LONG VIEW | PRSS1 CARRIES A CANCER RISK | A PRSS1 mutation raises the lifetime risk of pancreatic cancer by a large factor. | 5/7
  6. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | THE TAKEAWAY | A POSITIVE PRSS1 RESULT MEANS... | 1. Reframe the surgical strategy. Genetic disease continues in any remnant, so total pancreatectomy is a better option than partial resection. | 2. Counsel the family on an elevated lifetime pancreatic cancer risk. | 6/7
  7. Pancreas | Expert-to-Expert | Made possible by Cincinnati Children's | FOLLOW FOR MORE PEDIATRIC SURGERY EDUCATION. | 7/7
Intelligent Search· scoped to this carousel · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.